Hesperidin and Silibinin Ameliorate Aluminum-Induced Neurotoxicity: Modulation of Antioxidants and Inflammatory Cytokines Level in Mice Hippocampus

Biological Trace Element Research

Volumn 168, Issue 2, 2015, Pages 462-471

  Jangra, Ashok ^a   Kasbe, Prajapati ^a   Pandey, Surya Narayan ^a   Dwivedi, Shubham ^a   Gurjar, Satendra S ^a   Kwatra, Mohit ^a   Mishra, Murli ^b   Venu, Athira K ^a   Sulakhiya, Kunjbihari ^a   Gogoi, Ranadeep ^a   Sarma, Nitul ^a   Bezbaruah, Babul K ^c   Lahkar, Mangala ^a,c  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

^b UNIVERSITY OF KENTUCKY   (United States)

^c GAUHATI MEDICAL COLLEGE   (India)

Author keywords

Aluminum chloride; Hesperidin; Neurotoxicity; Oxido nitrosative stress; Proinflammatory cytokines; Silibinin

Indexed keywords

ACETYLCHOLINESTERASE; ALUMINUM CHLORIDE; BRAIN DERIVED NEUROTROPHIC FACTOR; CATALASE; GLUTATHIONE; HESPERIDIN; INTERLEUKIN 1BETA; NITRITE; SILIBININ; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ALUMINUM; ANTIOXIDANT; CYTOKINE; IL1B PROTEIN, MOUSE; NEUROPROTECTIVE AGENT; NITROGEN; SILYMARIN; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; LATENT PERIOD; LIPID PEROXIDATION; MALE; MORRIS WATER MAZE TEST; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NITROSATIVE STRESS; NONHUMAN; NOVEL OBJECT RECOGNITION TEST; OXIDATIVE STRESS; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; COGNITION DISORDERS; DRUG EFFECTS; ENZYMOLOGY; INFLAMMATION; MAZE TEST; METABOLISM; NERVE CELL; NEUROTOXICITY SYNDROMES;

ALUMINUM; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATALASE; COGNITION DISORDERS; CYTOKINES; GLUTATHIONE; HESPERIDIN; HIPPOCAMPUS; INFLAMMATION; INTERLEUKIN-1BETA; LIPID PEROXIDATION; MALE; MAZE LEARNING; MICE; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; NITROGEN; OXIDATIVE STRESS; SILYMARIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84947022268     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-015-0375-7     Document Type: Article

References (62)

1. Yokel RA, McNamara PJ (2001) Aluminium toxicokinetics: an updated mini-review. Pharmacol Toxicol 88:159–167
2. Kawahara M, Kato-Negishi M (2011) Link between aluminium and the pathogenesis of Alzheimer’s disease: the integration of the aluminum and amyloid cascade hypotheses. Int J Alzheimers Dis 2011:276393
3. Abdel-Hamid GA (2013) Effect of vitamin E and selenium against aluminium-induced nephrotoxicity in pregnant rats. Folia Histochem Cytobiol 51:312–319
4. Geyikoglu F (2013) The genotoxic, hepatotoxic, nephrotoxic, haematotoxic and histopathological effects in rats after aluminium chronic intoxication. Toxicol Ind Health 29:780–791
5. Kumar V, Gill KD (2014) Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: a review. Neurotoxicology 41:154–166
6. Tomljenovic L (2011) Aluminium and Alzheimer’s disease: after a century of controversy, is there a plausible link? J Alzheimers Dis 23:567–598
7. McLachlan DR, Kruck TP, Lukiw WJ, Krishnan SS (1991) Would decreased aluminium ingestion reduce the incidence of Alzheimer’s disease? CMAJ 145:793–804
8. Platt B, Fiddler G, Riedel G, Henderson Z (2001) Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence. Brain Res Bull 55:257–267
9. Exley C (2004) The pro-oxidant activity of aluminium. Free Radic Biol Med 36:380–387
10. Lukiw WJ, Percy ME, Kruck TP (2005) Nanomolar aluminium induces pro-inflammatory and pro-apoptotic gene expression in human brain cells in primary culture. J Inorg Biochem 99:1895–1898
11. Verstraeten SV, Aimo L, Oteiza PI (2008) Aluminium and lead: molecular mechanisms of brain toxicity. Arch Toxicol 82:789–802
12. Behl C (1997) Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 138:101–106
13. Kawahara M (2005) Effects of aluminium on the nervous system and its possible link with neurodegenerative diseases. J Alzheimers Dis 8:171–182
14. Prakash A, Shur B, Kumar A (2013) Naringin protects memory impairment and mitochondrial oxidative damage against aluminium-induced neurotoxicity in rats. Int J Neurosci 123:636–645
15. Prakash A, Kumar A (2009) Effect of N-acetyl cysteine against aluminium-induced cognitive dysfunction and oxidative damage in rats. Basic Clin Pharmacol Toxicol 105:98–104
16. Kumar A, Prakash A, Dogra S (2011) Neuroprotective effect of carvedilol against aluminium induced toxicity: possible behavioural and biochemical alterations in rats. Pharmacol Rep 63:915–923
17. Kakkar V, Kaur IP (2011) Evaluating potential of curcumin loaded solid lipid nanoparticles in aluminium induced behavioural, biochemical and histopathological alterations in mice brain. Food Chem Toxicol 49:2906–2913
18. Nedzvetsky VS (2006) Effects of vitamin E against aluminium neurotoxicity in rats. Biochemistry (Mosc) 71:239–244
19. Allagui MS, Feriani A, Saoudi M, Badraoui R, Bouoni Z, Nciri R, Murat JC, Elfeki A (2014) Effects of melatonin on aluminium-induced neurobehavioural and neurochemical changes in aging rats. Food Chem Toxicol 70:84–93
20. Gaur V, Kumar A (2010) Hesperidin pre-treatment attenuates NO-mediated cerebral ischemic reperfusion injury and memory dysfunction. Pharmacol Rep 62:635–648
21. Rong Z, Pan R, Xu Y, Zhang C, Cao Y, Liu D (2013) Hesperidin pretreatment protects hypoxia-ischemic brain injury in neonatal rat. Neuroscience 255:292–299
22. Kumar P, Kumar A (2010) Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington-like symptoms in rats: possible role of nitric oxide. Behav Brain Res 206:38–46
23. Kamisli S, Ciftci O, Kaya K, Cetin A, Kamisli O, Ozcan C (2013) Hesperidin protects brain and sciatic nerve tissues against cisplatin-induced oxidative, histological and electromyographical side effects in rats. Toxicol Ind Health p. 0748233713483192
24. Kumar A, Lalitha S, Mishra J (2013) Possible nitric oxide mechanism in the protective effect of hesperidin against pentylenetetrazole (PTZ)-induced kindling and associated cognitive dysfunction in mice. Epilepsy Behav 29:103–111
25. Köksal E, Gülçin I, Beyza S, Sarikaya O, Bursal E (2009) In vitro antioxidant activity of silymarin. J Enzyme Inhib Med Chem 24:395–405
26. Sangeetha N, Aranganathan S, Nalini N (2010) Silibinin ameliorates oxidative stress induced aberrant crypt foci and lipid peroxidation in 1, 2 dimethylhydrazine induced rat colon cancer. Investig New Drugs 28:225–233
27. Hou YC, Liou KT, Chern CM, Wang YH, Liao JF, Chang S, Chou YH, Shen YC (2010) Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF-kappaB and STAT-1 activation. Phytomedicine 17:963–73
28. Marrazzo G, Bosco P, La Delia F, Scapagnini G, Di Giacomo C, Malaguarnera M, Galvano F, Nicolosi A, Li Volti G (2011) Neuroprotective effect of silibinin in diabetic mice. Neurosci Lett 504:252–256
29. Lu P, Mamiya T, Lu LL, Mouri A, Niwa M, Hiramatsu M, Zou LB, Nagai T, Ikejima T, Nabeshima T (2009) Silibinin attenuates amyloid beta(25-35) peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-alpha in mice. J Pharmacol Exp Ther 331:319–326
30. + injection in rats. Pharmacol Biochem Behav 117:92–103
31. Kumar A, Dogra S, Prakash A (2009) Protective effect of curcumin (Curcuma longa), against aluminium toxicity: possible behavioural and biochemical alterations in rats. Behav Brain Res 205:384–390
32. Tota S, Kamat PK, Shukla R, Nath C (2011) Improvement of brain energy metabolism and cholinergic functions contributes to the beneficial effects of silibinin against streptozotocin induced memory impairment. Behav Brain Res 221:207–215
33. Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848–858
34. Leger M (2013) Object recognition test in mice. Nat Protoc 8:2531–2537
35. Ohkawa HN, Ohishi KY (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
36. Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882–888
37. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–138
38. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
39. Ellman GL, Courtney KD, Featherstone KM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:288–95
40. Bondy SC, Truong T (1999) Potentiation of beta-folding of beta-amyloid peptide 25-35 by aluminium salts. Neurosci Lett 267:25–28
41. Becaria A, Bondy SC, Campbell A (2003) Aluminium and copper interact in the promotion of oxidative but not inflammatory events: implications for Alzheimer’s disease. J Alzheimers Dis 5:31–38
42. Walton JR (2012) Cognitive deterioration and associated pathology induced by chronic low-level aluminium ingestion in a translational rat model provides an explanation of Alzheimer’s disease, tests for susceptibility and avenues for treatment. Int J Alzheimers Dis. doi:10.1155/2012/914947
43. Bolla KI, Briefel G, Spector D, Schwartz BS, Wieler L, Herron J, Gimenez L (1992) Neurocognitive effects of aluminium. Arch Neurol 49:1021–1026
44. Bharathi, Shamasundar NM, Sathyanarayana Rao TS, Dhanunjaya Naidu M, Ravid R, Rao KS (2006) A new insight on Al-maltolate-treated aged rabbit as Alzheimer’s animal model. Brain Res Rev 52:275–292
45. Ghribi O (2002) Lithium inhibits aluminium-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation. J Neurochem 82:137–145
46. Jovanovic SV, Steenken S, Tosic M, Marjanovic B, Simic MG (1994) Flavonoids as antioxidants. J Am Chem Soc 116:4846–4851
47. Dehmlow C, Murawski N, de Groot H (1996) Scavenging of reactive oxygen species and inhibition of arachidonic acid metabolism by silibinin in human cells. Life Sci 58:1591–1600
48. Campbell A, Becaria A, Lahiri DK, Sharman K, Bondy SC (2004) Chronic exposure to aluminium in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 75:565–572
49. Mannello F, Ligi D, Canale M (2013) Aluminium, carbonyls and cytokines in human nipple aspirate fluids: possible relationship between inflammation, oxidative stress and breast cancer microenvironment. J Inorg Biochem 128:250–256
50. Campbell A, Yang EY, Tsai-Turton M, Bondy SC (2002) Pro-inflammatory effects of aluminium in human glioblastoma cells. Brain Res 933:60–65
51. Sulakhiya K, Kumar P, Jangra A, Dwivedi S, Hazarika NK, Baruah CC, Lahkar M (2014) Honokiol abrogates lipopolysaccharide-induced depressive like behaviour by impeding neuroinflammation and oxido-nitrosative stress in mice. Eur J Pharmacol 744:124–131
52. Johnson VJ, Sharma RP (2003) Aluminium disrupts the pro-inflammatory cytokine/neurotrophin balance in primary brain rotation-mediated aggregate cultures: possible role in neurodegeneration. Neurotoxicology 24:261–268
53. Kawahara M, Kato-Negishi M, Hosoda R, Imamura L, Tsuda M, Kuroda Y (2003) Brain-derived neurotrophic factor protects cultured rat hippocampal neurons from aluminium maltolate neurotoxicity. J Inorg Biochem 97:124–131
54. Zhang L, Jin C, Lu X, Yang J, Wu S, Liu Q, Chen R, Bai C, Zhang D, Zheng L, Du Y, Cai Y (2014) Aluminium chloride impairs long-term memory and downregulates cAMP-PKA-CREB signalling in rats. Toxicology 323:95–108
55. Kumar A, Chaudhary T, Mishra J (2013) Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington’s disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences. Eur J Pharmacol 720:16–28
56. Duan S, Guan X, Lin R, Liu X, Yan Y, Lin R, Zhang T, Chen X, Huang J, Sun X, Li Q, Fang S, Xu J, Yao Z, Gu H (2015) Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for Alzheimer’s disease treatment. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2015.02.002
57. Wang J, Zhang HY, Tang XC (2009) Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment. Acta Pharmacol Sin 30:879–888
58. Rinwa P, Kumar A (2014) Modulation of nitrergic signalling pathway by American ginseng attenuates chronic unpredictable stress-induced cognitive impairment, neuroinflammation, and biochemical alterations. Naunyn Schmiedeberg’s Arch Pharmacol 387:129–141
59. Jangra A, Datusalia AK, Khandwe S, Sharma SS (2013) Amelioration of diabetes-induced neurobehavioral and neurochemical changes by melatonin and nicotinamide: implication of oxidative stress-PARP pathway. Pharmacol Biochem Behav 114:43–51
60. Jangra A, Datusalia AK, Sharma SS (2013) Reversal of neurobehavioral and neurochemical alterations in STZ-induced diabetic rats by FeTMPyP, a peroxynitrite decomposition catalyst and 1, 5-Isoquinolinediol a poly (ADP-ribose) polymerase inhibitor. Neurol Res 36:619–626
61. Thenmozhi AJ, Raja TR, Janakiraman U, Manivasagam T (2015) Neuroprotective effect of hesperidin on aluminium chloride induced Alzheimer’s disease in Wistar rats. Neurochem Res. doi:10.1007/s11064-015-1525-1
62. Remya C, Dileep KV, Tintu I, Variyar EJ, Sadasivan C (2014) Flavanone glycosides as acetylcholinesterase inhibitors: computational and experimental evidence. Indian J Pharm Sci 76:567–570